J Thor Onc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from J thor onc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In J Thor Onc Today - Breaking & Trending Today

Taletrectinib Under NMPA Review in China for Advanced or Metastatic ROS1+ NSCLC

The Center for Drug Evaluation of China’s National Medical Products Administration has accepted the new drug application seeking the approval of the next-generation ROS1 TKI taletrectinib for the treatment of patients with locally advanced or metastatic ROS1-positive non-small cell lung cancer with prior exposure to a ROS1 TKI. ....

Rhui Zhou , Bing Yan , Caicun Zhou , J Thor Onc , China National Medical Products Administration , Drug Evaluation , National Medical Products Administration , Shanghai Pulmonary Hospital , Heart Therapeutics , Ros1 Nsclc , Ros1 Tki ,